Narrow Aduhelm coverage sparks debate over viability of future treatments
At the same time, the decision put an unflattering spotlight on the Food and Drug Administration’s accelerated approval process and ...
Read moreTag: aduhelm
Medicare will cover Aduhelm only for those enrolled in clinical trials
CMS updated its stance on future Alzheimer’s drugs that also target the amyloid proteins thought to cause the disease. Should ...
Read more
How the Alzheimer’s drug Aduhelm posed a real challenge to Medicare officials
Aduhelm, a drug developed recently by Biogen BIIB, +1.75%, has raised enormously important issues for Medicare. Biogen’s initial proposed price ...
Read more
Medicare proposes to only cover Alzheimer’s drug aduhelm for use in clinical trials
Diagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain. (HealthDay)—It's a move that could severely limit ...
Read more
